HITECH Final Rule: Meaningful Use Implications

Christopher Brancato, Consulting Specialist Leader, and Mitchell Morris, MD, Principal, Deloitte Consulting, LLP. Dr. Morris and Mr. Brancato will present an analysis of and Deloitte’s Point of View on Meaningful Use Stage #1. The discussion will include an explanation of incentives and penalties, assessment of the current market response to the new rule, highlights of significant challenges that health systems face, and will identify the highest priority action items to consider.